News
Johnson & Johnson must pay more than $42 million to a Massachusetts man who alleges that he developed mesothelioma, a rare ...
Barchart on MSN9h
Johnson & Johnson Stock: Analyst Estimates & Ratings
New Brunswick, New Jersey-based Johnson & Johnson (JNJ) primarily focuses on drug discovery and manufacturing but has a diversified business model. With a market cap of $402.8 billion, Johnson & ...
Boston Jury Awards $42.6 Million to Massachusetts Man in Mesothelioma Case Against Johnson & Johnson
A Boston jury awarded a Massachusetts family $42.6 million in a lawsuit against Johnson & Johnson, claiming the company's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback